packageDarifenacin

darifenacin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Darifenacin is a muscarinic antagonist used to treat urinary frequency and incontinence, such as in overactive bladder. It is an approved drug, though it does not appear to be authorised centrally in the European Union.

Summary written by glm-5.3-flash from Wikidata Q166476 and the WHO ATC classification; not checked by a person.

name:darifenacin
ATC codes:G04BD10
DrugBank:DB00496
PubChem CID:444031
ChEBI:391960
Wikidata:Q166476
formula:C28H30N2O2
molar mass:426.56 g/mol (PubChem CID 444031)
logP:4.6 (Drugs.Common 25.09, not verified)

Metabolites

HydroxylatedMetabolitehydroxylated metabolite442.559 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
HydroxylatedMetabolitemetabolite: hydroxylated metabolite